Kimura Masayo, Yasukawa Tsutomu, Shibata Yu, Kato Aki, Hirano Yoshio, Uemura Akiyoshi, Yoshida Munenori, Ogura Yuichiro
Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-ku, Nagoya, Aichi, 467-8601, Japan.
Graefes Arch Clin Exp Ophthalmol. 2018 Oct;256(10):1823-1829. doi: 10.1007/s00417-018-4059-9. Epub 2018 Jul 1.
Pneumatic displacement of submacular hemorrhages (SMHs) with intravitreal injection of sulfur hexafluoride (SF) gas with or without tissue plasminogen activator (tPA) and prone posturing is an effective minimally invasive treatment. We observed some cases in which simultaneous flattening of hemorrhagic pigment epithelial detachments (PEDs) occurred after prone posturing. This study evaluated the impact of pneumatic displacement using tPA to treat PEDs and visual outcomes in eyes with SMHs secondary to neovascular age-related macular degeneration (AMD).
This retrospective analysis reviewed the medical records of 32 patients (33 eyes) who underwent pneumatic displacement for AMD-associated SMHs. The SMHs were related to polypoidal choroidal vasculopathy (PCV) in 24 eyes and typical AMD in nine eyes and treated with intravitreal injection of SF gas with tPA. We assessed the postoperative best-corrected visual acuities (BCVAs), prevalence and flattening rates of the PEDs, and the number of additional treatments.
The mean follow-up period was 35.4 ± 19.8 months. The BCVAs improved significantly in eyes with PCV compared with eyes with typical AMD. Thirty-one (93.9%) of 33 eyes had an accompanying PED. The PEDs flattened in 14 (58.3%) of 24 eyes with PCV but in only one (14.3%) of seven eyes with typical AMD (p = 0.04). A mean of one additional treatment was administered during the first year in 15 eyes with flattened PEDs, which was significantly (p < 0.05) fewer than the 3.6 additional treatments in 16 eyes with persistent PEDs.
PEDs often accompany SMHs secondary to neovascular AMD. Pneumatic displacement of the SMHs using tPA unexpectedly flattened the PEDs, especially in eyes with PCV, and was associated with fewer additional treatments.
玻璃体腔内注射六氟化硫(SF)气体,伴或不伴组织型纤溶酶原激活剂(tPA),并采取俯卧位姿势进行黄斑下出血(SMH)的气体置换是一种有效的微创治疗方法。我们观察到一些病例,在俯卧位姿势后出血性色素上皮脱离(PED)同时变平。本研究评估了使用tPA进行气体置换治疗PED的效果以及对新生血管性年龄相关性黄斑变性(AMD)继发SMH的眼睛的视力结果。
这项回顾性分析回顾了32例(33只眼)因AMD相关SMH接受气体置换的患者的病历。24只眼中的SMH与息肉状脉络膜血管病变(PCV)有关,9只眼与典型AMD有关,并接受了玻璃体腔内注射含tPA的SF气体治疗。我们评估了术后最佳矫正视力(BCVA)、PED的患病率和平坦率以及额外治疗的次数。
平均随访期为35.4±19.8个月。与典型AMD的眼睛相比,PCV眼睛的BCVA有显著改善。33只眼中的31只(93.9%)伴有PED。24只PCV眼睛中的14只(58.3%)PED变平,但7只典型AMD眼睛中只有1只(14.3%)PED变平(p = 0.04)。在第一年,15只PED变平的眼睛平均接受了1次额外治疗,这明显(p < 0.05)少于16只PED持续存在的眼睛的3.6次额外治疗。
PED常伴随新生血管性AMD继发的SMH。使用tPA对SMH进行气体置换意外地使PED变平,尤其是在PCV眼睛中,并且额外治疗次数较少。